Status: Recruiting
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges
The goal of this exploratory study is to evaluate the effects of inhaled epinephrine in subjects, who may not be eligible for the GHL-101 trial, and who are experiencing systemic allergic reaction (SAR) that occur following allergy testing, subcutaneous immunotherapy (SCIT), oral challenges (with food and/or drug) or oral immunotherapy (OIT).
Participants needed: 100
Trial details
Phase: Phase 1Age: 12+Biological sex: AllType: InterventionalSponsor: Dr. George LuciukUpdated: Feb 5, 2026Locations: 1
Eligibility criteria
Males or females, aged ≥ 12 years with known or suspected allergen sensitivity w... [+2]
Known reaction or sensitivity to epinephrine or any of the ingredients of inhale... [+6]